SCILEX Pharmaceuticals
Call now
Call now
Website
Call
We're committed to harnessing the power of revolutionary delivery technologies designed to safely and effectively provide therapies to those who need them most. With a passion for patients and a dedication to innovation, SCILEX is lighting the way forward in pain management. Scilex Holding Company, a Sorrento Therapeutics, Inc. Subsidiary Announces Expansion of Ztlido Managed Care Coverage for Additional 33 Million Lives.

At SCILEX, we believe that innovation is the path to improving therapeutic outcomes in pain management. We believe our advances in this area are evidence of our tireless dedication to optimizing the patient experience.
Services
Drug delivery through intact skin has been around for ages, 1 but it's still far from perfect. See how we're engineering patch systems to efficiently deliver medicine through the skin. Our adhesive and pliable properties are designed to permit reliable skin contact throughout the dosing regimen. SCILEX employs anhydrous, single-layer, drug-in-adhesive, topical delivery system technology to keep its patches thin and drug delivery locally targeted.
SCILEX is more than just a pharmaceutical company. It's a team of passionate and dedicated people who have faith in forward-thinking technologies and who believe that helping patients better manage their pain can lead toward a better quality of life. Learn more about the people who make up what we think is a pretty amazing place.
At SCILEX, we're excited to develop and commercialize innovative pain management solutions to help improve patient care. Learn more about what's going on at SCILEX. Scilex Holding, a majority-owned subsidiary of Sorrento, is a commercial-stage, non-opioid pain management company focused on the development and commercialization of topical and injectable therapies.
Reviews
Review SCILEX Pharmaceuticals

Be the first to review SCILEX Pharmaceuticals.

Write a Review